Browse 23 Health Care companies funded by New Enterprise Associates. See funding amounts, founder contacts, and investment details.
Tempus develops AI-enabled precision medicine technology that supports clinical decision-making and biomedical research.
Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.
AviadoBio transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.
Qualified Health develops artificial intelligence tools that support clinical decision-making and patient care management.
Strive Health is a value-based kidney care provider with an integrated system supporting the journey of individuals with kidney disease.
Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.
SetPoint Medical provides a device-based therapy for rheumatoid arthritis.
Elion is a digital health software marketplace for healthcare providers.
Belong Health works with local health plans to provide regionally informed, humanistic care to a rapidly expanding community of need.
Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation.
Vori Health offers a nationwide, all-inclusive medical practice that is uniquely positioned to address back, neck, and other joint issues.
ChromaCode is a molecular diagnostics company focusing on bioinformatics.
Tune Therapeutics is an epigenetic programming platform for the treatment of disease.
FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.
858 Therapeutics develops small molecule drugs targeting oncology and immunology.
Moximed develops innovative therapies for patients with knee osteoarthritis.
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
U.S. Renal Care is a healthcare service provider that focuses on serving patients in dialysis facilities.
Waymark is a company dedicated to improving access and quality of care for people receiving Medicaid.
View all companies funded by New Enterprise Associates across every industry and funding stage.
View Full New Enterprise Associates Portfolio